Clinical Trial Update: Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy [NA]

View source ↗

Summary

A clinical trial update examining pharmacokinetic-guided dosing of docetaxel and paclitaxel in non-small cell lung cancer, nasopharyngeal carcinoma, and breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer, Breast Cancer | NA | Status: UNKNOWN